StonvexLoading…
StonvexStonvexStonvexCore line items from AJG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.94B | $11.55B | $10.07B | $8.55B |
Operating Income | $1.87B | $1.88B | $1.19B | $1.33B |
Net Income | $1.49B | $1.46B | $970.00M | $1.11B |
EPS (Diluted) | $5.74 | $6.50 | $4.42 | $5.19 |
Total Assets | $70.67B | $64.25B | $51.62B | $38.36B |
Total Liabilities | $47.32B | $44.08B | $40.80B | $29.17B |
Cash & Equivalents | $1.40B | $14.99B | $971.00M | $738.40M |
Free Cash Flow OCF − CapEx | $1.78B | $2.44B | $1.84B | $1.21B |
Shares Outstanding | 257.00M | 250.00M | 216.70M | 211.90M |